Novartis shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and lowered its price target to $130.
Portfolio Pulse from Benzinga Newsdesk
Novartis shares declined following a downgrade by B of A Securities from Buy to Neutral, with a reduced price target of $130.

September 11, 2024 | 11:43 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Novartis shares are under pressure after B of A Securities downgraded the stock from Buy to Neutral and reduced the price target to $130.
The downgrade from Buy to Neutral by a major financial institution like B of A Securities is likely to negatively impact investor sentiment, leading to a short-term decline in Novartis' stock price. The reduced price target to $130 further supports this negative outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100